Latest Breaking News On - Blackbox warning - Page 1 : vimarsana.com

An analysis of the ORAL Surveillance trial details the efficacy of tofacitinib relative to TNF inhibition based on history of ASCVD and baseline cardiovascular risk.

United statesGeorge karpouzasDeepak bhattDavid geffen school of medicineAmerican college of rheumatologyEuropean congressDivision of rheumatology atLundquist institute george karpouzasLundquist instituteBlackbox warningDavid geffen schoolNew england journalAmerican collegeCancer risk